Clinical Trial Update: Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With Schizophrenia [Phase 3]

View source ↗

Summary

Open-label Phase 3 study assessing safety and tolerability of flexible-dose brexpiprazole as maintenance treatment in adolescents with schizophrenia; results ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Brexpiprazole (Rexulti) (brexpiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2026-02-04